Abbott India Share Price
20 Nov, 2026 3:54 PM (IST)
Abbott India Performance
- Today's Low
- ₹25,635
- Today's High
- ₹26,670
- 52 Week Low
- ₹24,650
- 52 Week High
- ₹30,655
- Open Price₹25,820
- Previous Close₹25,695
- Volume11,929
- 50 DMA₹26,218.90
- 100 DMA₹26,422.00
- 200 DMA₹26,906.40
Abbott India Chart
Investment Returns
- Over 1 Month + 2.39%
- Over 3 Month + 1.55%
- Over 6 Month -3.35%
- Over 1 Year -10.34%
Smart Investing Starts Here Start SIP with Abbott India for Steady Growth!
Abbott India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 34.1
- PEG Ratio
- 3.6
- Market Cap Cr
- 56,364
- P/B Ratio
- 10.8
- Average True Range
- 646
- EPS
- 777.8
- Dividend Yield
- 2.5
- MACD Signal
- -20.4
- RSI
- 54.1
- MFI
- 55.77
Latest Stock News Updates
<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Abbott India announced Q2FY27 results</strong></span></h3> <p><strong>Financial Highlights:</strong></p> <ul data-complete="true" data-hveid="CAAIChAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="RjAONe_1t"> <li data-complete="true" data-hveid="CAAIChAC" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_1w"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_1y">Revenue from operations:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue from operations was recorded at Rs 1,951.01 crore, displaying a growth of 7.57% QoQ from Rs 1,813.68 crore in Q1FY27 and a growth of 11.03% YoY from Rs 1,757.15 crore in Q2FY26. For H1FY27, revenue from operations reached Rs 3,764.69 crore, demonstrating a YoY growth of 7.7% against Rs 3,495.50 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAF" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_26"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_28">Total income:<!--TgQPHd|||[]--></strong> For Q2FY27, total income stood at Rs 2,019.07 crore, increasing by 6.88% QoQ from Rs 1,889.05 crore in Q1FY27 and up 10.51% YoY from Rs 1,827.10 crore in Q2FY26. For H1FY27, total income amounted to Rs 3,908.12 crore, up 7.42% YoY compared to Rs 3,638.29 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAI" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_2g"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_2i">Profit Before Tax (PBT):<!--TgQPHd|||[]--></strong> For Q2FY27, PBT reached Rs 610.47 crore, scaling up by 6.69% QoQ from Rs 572.21 crore in Q1FY27 and increasing by 11.82% YoY from Rs 545.93 crore in Q2FY26. For H1FY27, PBT expanded to Rs 1,182.68 crore, growing by 13.82% YoY against Rs 1,039.05 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAL" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_2q"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_2s">Profit After Tax (PAT):<!--TgQPHd|||[]--></strong> For Q2FY27, PAT or net profit was reported at Rs 453.45 crore, higher by 5.82% QoQ than Rs 428.52 crore in Q1FY27 and higher by 9.19% YoY than Rs 415.27 crore in Q2FY26. For H1FY27, PAT stood at Rs 881.97 crore, showing a YoY growth of 12.91% compared to Rs 781.13 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAO" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="RjAONe_30"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="RjAONe_32">Earnings per share (EPS):<!--TgQPHd|||[]--></strong> For Q2FY27, basic and diluted EPS was recorded at Rs 213.39, expanding by 5.82% QoQ from Rs 201.66 in Q1FY27 and growing by 9.2% YoY over Rs 195.42 in Q2FY26. For H1FY27, basic and diluted EPS stood at Rs 415.04, reflecting a YoY growth of 12.91% compared to Rs 367.59 in H1FY26.<!--TgQPHd|||[]--></li> </ul> <p> </p> <p><a class="lb" href="/get-document/post/pdf/5934828/" target="_blank">Result PDF</a></p>
- Trendlyne
- 2 weeks 1 day ago
Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.
- BSE India
- 2 weeks 2 days ago
Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.
- BSE India
- 2 weeks 2 days ago
Abbott India Financials
Abbott India Technicals
EMA & SMA
- Bearish Moving Average 4
- Bullish Moving Average 12
- 20 Day
- ₹26,119.50
- 50 Day
- ₹26,218.90
- 100 Day
- ₹26,422.00
- 200 Day
- ₹26,906.40
Resistance and Support
- R3 27,953.30
- R2 27,311.70
- R1 26,918.30
- S1 25,883.30
- S2 25,241.70
- S3 24,848.30
Abbott India Corporate Actions - Bonus, Splits, Dividends
About Abbott India
Abbott India is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country. View More- NSE Symbol
- ABBOTINDIA
- BSE Symbol
- 500488
- ISIN
- INE358A01014
Similar Stocks to Abbott India
Popular Stocks
Abbott India FAQs
Abbott India share price is ₹26,525 As on 22 November, 2026 | 05:25
The Market Cap of Abbott India is ₹56363.8 Cr As on 22 November, 2026 | 05:25
The P/E ratio of Abbott India is 34.1 As on 22 November, 2026 | 05:25
The PB ratio of Abbott India is 10.8 As on 22 November, 2026 | 05:25
The 52 week High & Low of Abbott India is ₹30655/₹24650 respectively As on 22 November, 2026 | 05:25
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.